AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
Each Tablet Contains: Etoricoxib 90,0 Mg
9 registrations across 1 African market— 9 active
Markets with Each Tablet Contains: Etoricoxib 90,0 Mg
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| BRUTASULT 90 | 🇿🇦South Africa | Evohealth (Pty) Ltd | active | Jun 2031 |
| EXTRIB 90 mg | 🇿🇦South Africa | Pharma Dynamics (Pty) Ltd | active | May 2031 |
| ETORICOXIB 90 BIOTECH | 🇿🇦South Africa | Biotech Laboratories (Pty) Ltd | active | Mar 2031 |
| AZCURA 90 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Jan 2031 |
| ETORICOXIB ZYDUS 90 | 🇿🇦South Africa | Zydus Healthcare (Pty) Ltd | active | Jan 2031 |
| ETIFLAM 90 | 🇿🇦South Africa | Cipla Medpro (Pty) Ltd | active | Jan 2031 |
| THRYTIX 90 | 🇿🇦South Africa | Ranbaxy (SA) (Pty) Ltd | active | Dec 2030 |
| EBOV 90 | 🇿🇦South Africa | Activo Health (Pty) Ltd | active | Nov 2030 |
| ECOXAR 90 | 🇿🇦South Africa | Ranbaxy Pharmaceutical (Pty) Ltd | active | Nov 2025 |
Each Tablet Contains: Etoricoxib 90,0 Mg in Africa — Regulatory Overview
Each Tablet Contains: Etoricoxib 90,0 Mg is registered across 1 African markets with 9 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.
Of the 9 registrations, 9 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.